Pages that link to "Q47634506"
Jump to navigation
Jump to search
The following pages link to Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity (Q47634506):
Displaying 50 items.
- CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin (Q21562452) (← links)
- Genomic variability within an organism exposes its cell lineage tree (Q21563514) (← links)
- Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1 (Q24293178) (← links)
- Efficient tumour formation by single human melanoma cells (Q24648938) (← links)
- Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice (Q24669724) (← links)
- The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells (Q24670343) (← links)
- The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis (Q24683173) (← links)
- Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? (Q26746104) (← links)
- Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells? (Q26747513) (← links)
- Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting (Q26752688) (← links)
- The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells (Q26765892) (← links)
- Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia (Q26799954) (← links)
- Metastatic cancer stem cells: from the concept to therapeutics (Q26850739) (← links)
- Oxidative stress responses and NRF2 in human leukaemia (Q26864239) (← links)
- Nanomedicine therapeutic approaches to overcome cancer drug resistance (Q27011692) (← links)
- An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging (Q27311229) (← links)
- Development of Selective Inhibitors for Aldehyde Dehydrogenases Based on Substituted Indole-2,3-diones (Q27681402) (← links)
- A human colon cancer cell capable of initiating tumour growth in immunodeficient mice (Q27860831) (← links)
- Identification of human brain tumour initiating cells (Q27860921) (← links)
- Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities (Q28071384) (← links)
- DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders (Q28073970) (← links)
- Imaging metabolic heterogeneity in cancer (Q28076500) (← links)
- Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? (Q28081844) (← links)
- Cancer stem cells: the lessons from pre-cancerous stem cells (Q28259527) (← links)
- Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma (Q28286168) (← links)
- Cancer stem cells in solid tumours: accumulating evidence and unresolved questions (Q28293535) (← links)
- Tissue repair and stem cell renewal in carcinogenesis (Q28294006) (← links)
- Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo (Q28504560) (← links)
- Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents (Q28546911) (← links)
- The difficulty of targeting cancer stem cell niches (Q28744461) (← links)
- Tumour stem cells and drug resistance (Q29617742) (← links)
- Cells of origin in cancer (Q29619557) (← links)
- Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells (Q30252566) (← links)
- Notch inhibitors as a new tool in the war on cancer: a pathway to watch (Q30426621) (← links)
- Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib (Q30873646) (← links)
- Precancerous stem cells have the potential for both benign and malignant differentiation (Q33278288) (← links)
- Prepatterning in the stem cell compartment (Q33598286) (← links)
- Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. (Q33622409) (← links)
- Lymphoma stem cells: enough evidence to support their existence? (Q33632266) (← links)
- A two-mutation model of radiation-induced acute myeloid leukemia using historical mouse data (Q33692979) (← links)
- Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies (Q33730375) (← links)
- The Therapeutic Implications of Plasticity of the Cancer Stem Cell Phenotype (Q33778409) (← links)
- Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity (Q33802690) (← links)
- Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts (Q33863533) (← links)
- Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. (Q33885674) (← links)
- Identification and targeting of cancer stem cells (Q33921460) (← links)
- New promising drug targets in cancer- and metastasis-initiating cells (Q34003691) (← links)
- Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells (Q34063522) (← links)
- Cancer stem cells: a stride towards cancer cure? (Q34086837) (← links)
- Direct conversion of human fibroblasts to multilineage blood progenitors. (Q34148584) (← links)